According to United States Aluminum Company Alcoa Inc. (NYSE:AA) said that, global demand for aluminum will keep surging and has exceeded initial expectation of growth rate from 2010 to 2020. So far, Alcoa is achieving its target of fiscal year in 2014. Alcoa Inc. (NYSE:AA) in last trading activity fell -0.06% to close at $16.32. Company weekly performance is -3.43% while its quarterly performance stands at 0.99%. Alcoa Inc. (NYSE:AA) is -5.83% away from its 52 week high.
BioMarin Pharmaceutical (NASDAQ:BMRN) CEO Jean Jacques Bienaime sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $85.33, for a total transaction of $255,990.00. Following the completion of the transaction, the chief executive officer now directly owns 229,157 shares of the company’s stock, valued at approximately $19,553,967. On last trading day BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) advanced 4.40% to close at $87.60. Its volatility for the week is 2.74% while volatility for the month is 3.63%. BMRN’s sales growth for past 5 years was 13.10% and its EPS growth for past 5 years was -44.30%. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) monthly performance is 23.73%.
On November 4, For third-quarter 2014, deposition equipment maker Aixtron SE (NASDAQ:AIXG) of Aachen, Germany has reported revenue of €45.6m, down just 1.3% on €46.2m both last quarter and a year ago. The utilization rates of most tier-one LED chip makers have recently fallen, notes the firm. On last trading day Aixtron SE (NASDAQ:AIXG) decreased -2.34% to close at $11.68. Its volatility for the week is 1.86% while volatility for the month is 2.14%. AIXG’s sales growth for past 5 years was -7.80% and its EPS growth for past 5 years was -42.20%. Aixtron SE (NASDAQ:AIXG) monthly performance is -11.92%.
On October 29, Magellan Health Inc. (NASDAQ:MGLN) experienced a more than 40% drop in net income during the third quarter that ended Sept. 30, attributable to a higher tax rate that resulted from the health insurance fee outlined in the Patient Protection and Affordable Care Act, the Avon, Conn.-based healthcare management company reported. Full-year expense related to the fee will be approximately $21 million, the company estimated. Magellan Health, Inc. (NASDAQ:MGLN) has 0.60% insider ownership while its institutional ownership stands at 98.50%. In last trading activity company’s stock closed at $60.48.
Trio-Tech International (NYSEMKT:TRT) reported the results of the fourth quarter and fiscal2014.The revenues in 4Q2014 came rose 10.2% compared to the same period a year ago. The net income came at $0.07 per share comparable to $0.01 per share in 4Q2013. The revenue of Trio-Tech for the year rose 14.1% compared to a year ago. The net income rose to $0.01 compared to a loss of $0.31 per share for FY13. On Monday shares of Trio-Tech International (NYSEMKT:TRT) closed at $3.44. Company’s sales growth for last 5 years was 12.70%.